Education
About Us
Working with TipRanks
Follow Us
GE Healthcare Technologies Inc (GEHC)
NASDAQ:GEHC
RESEARCH TOOLSreports
GEHC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$57.65 - $94.80
Previous CloseN/A
Volume1.76M
Average Volume (3M)5.28M
Market Cap
$30.71B
Enterprise Value$42.58B
Total Cash (Recent Filing)$2.87B
Total Debt (Recent Filing)$1.50B
Price to Earnings (P/E)15.4
Beta1.22
Next Earnings
Apr 30, 2025EPS Estimate
0.91Last Dividend Ex-Date
Apr 25, 2025Dividend Yield0.19%
Share Statistics
EPS (TTM)4.34
Shares Outstanding457,843,170
10 Day Avg. Volume6,088,618
30 Day Avg. Volume5,276,733
Financial Highlights & Ratios
PEG Ratio0.36
Price to Book (P/B)N/A
Price to Sales (P/S)1.89
Price to Cash Flow (P/CF)10.20
P/FCF Ratio9.20
Enterprise Value/Market Cap1.39
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit5.19
Enterprise Value/Ebitda11.59
Forecast
1Y Price Target
$96.55Price Target Upside43.93% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering12
---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceThe bullish backdrop in US radiology and the potential of FLYRCADO could drive upside to full-year numbers.
Market PositionGE HealthCare is the only company with both imaging equipment and pharmaceutical diagnostics, allowing for strong synergy between diagnostic pharmaceuticals and imaging.
Product InnovationFlyrcado offers a significantly longer half-life relative to current options on the market allowing for both pharmacologic and exercise stress testing for coronary artery disease.
Bears Say
Economic EnvironmentThere is a broader concern that a global recession could weaken hospital capital expenditures globally, affecting GEHC.
Market CompetitionGE HealthCare’s products are priced at a premium compared to Chinese peers, which may lead to hospitals moving to purchase Chinese products more, posing a risk to GE HealthCare’s China business.
Trade And TariffsRetaliatory actions by China could disrupt GEHC’s supply chain, particularly with limitations on exports of rare elements used in some products.
---
Ownership Overview
0.23% Insiders
33.90% Mutual Funds
0.46% Other Institutional Investors
36.64% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
GEHC FAQ
What was GE Healthcare Technologies Inc’s price range in the past 12 months?
GE Healthcare Technologies Inc lowest stock price was $57.65 and its highest was $94.80 in the past 12 months.
What is GE Healthcare Technologies Inc’s market cap?
GE Healthcare Technologies Inc’s market cap is $30.71B.
When is GE Healthcare Technologies Inc’s upcoming earnings report date?
GE Healthcare Technologies Inc’s upcoming earnings report date is Apr 30, 2025 which is in 4 days.
How were GE Healthcare Technologies Inc’s earnings last quarter?
GE Healthcare Technologies Inc released its earnings results on Feb 13, 2025. The company reported $1.45 earnings per share for the quarter, beating the consensus estimate of $1.263 by $0.187.
Is GE Healthcare Technologies Inc overvalued?
According to Wall Street analysts GE Healthcare Technologies Inc’s price is currently Undervalued.
Does GE Healthcare Technologies Inc pay dividends?
GE Healthcare Technologies Inc pays a Quarterly dividend of $0.035 which represents an annual dividend yield of 0.19%. See more information on GE Healthcare Technologies Inc dividends here
What is GE Healthcare Technologies Inc’s EPS estimate?
GE Healthcare Technologies Inc’s EPS estimate is 0.91.
How many shares outstanding does GE Healthcare Technologies Inc have?
GE Healthcare Technologies Inc has 457,843,170 shares outstanding.
What happened to GE Healthcare Technologies Inc’s price movement after its last earnings report?
GE Healthcare Technologies Inc reported an EPS of $1.45 in its last earnings report, beating expectations of $1.263. Following the earnings report the stock price went up 8.817%.
Which hedge fund is a major shareholder of GE Healthcare Technologies Inc?
Currently, no hedge funds are holding shares in GEHC
---
GE Healthcare Technologies Inc Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$96.55 (43.93% Upside)
$96.55 (43.93% Upside)
Blogger Sentiment
Bullish
GEHC Sentiment 91%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 99.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $185.1K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 0.2%
Last 30 Days ▼ 0.3%
Last 30 Days ▼ 0.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-22.56%
12-Months-Change
Fundamentals
Return on Equity
25.60%
Trailing 12-Months
Asset Growth
1.96%
Trailing 12-Months
Company Description
GE Healthcare Technologies Inc
GE Healthcare Technologies Inc (GEHC) is a leading global provider of medical imaging, monitoring, biomanufacturing, and cell and gene therapy technologies. The company operates in various sectors including diagnostic imaging, ultrasound, life care solutions, and enterprise digital solutions. Its core products and services are designed to enable precision health, improve patient outcomes, and enhance operational efficiency in healthcare facilities worldwide.
---
GEHC Company Deck
---
GEHC Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted significant achievements in margin expansion, order growth, and strategic partnerships, alongside a record backlog. However, the company faced challenges in the China market and a decline in free cash flow, which affected overall performance. The guidance for 2025 reflects cautious optimism with continued investments in innovation and strategic partnerships.Read More>---
GEHC Revenue Breakdown
45.01% Imaging
26.08% AVS
15.89% PCS
12.75% PDx
0.26% Other
---
GEHC Stock 12 Month Forecast
Average Price Target
$96.55
▲(43.93% Upside)
Technical Analysis
Veeva Systems
―
Healthequity
―
Privia Health Group
―
Doximity
―
BrightSpring Health Services, Inc.
―
Best Analysts Covering GEHC
1 Year
1 Year Success Rate
5/9 ratings generated profit
1 Year Average Return
+1.04%
reiterated a buy rating 2 months ago
Copying Joanne Wuensch's trades and holding each position for 1 Year would result in 55.56% of your transactions generating a profit, with an average return of +1.04% per trade.
---